Specialty CompassAustralian specialty training guide
Home / Specialties / Medical Oncology

Medical Oncology

RACP. Systemic cancer therapy in the immunotherapy era, a rapidly expanded specialty with deep clinics and a big clinical-trials engine.

Medicine (physician)3 years ATCompetitiveness: highSubspecialty, entry via Basic Physician Training (Adult Medicine)
Competition snapshot: High   Tertiary/trials-centre posts contested; overall expanded intake has eased entry vs a decade ago (indicative)
Program length
3 years AT
Typical entry
AT from PGY5–6
Women (trainees)
≈ 60% of trainees
Consultant (public)
$300,000–460,000 package
Consultant (private)
$350,000–650,000 (private infusion sector) (indicative)
Hours & lifestyle
Clinic-heavy; inpatient consults; emotionally intense rather than hours-brutal
Entry routeYou enter Medical Oncology through Basic Physician Training (Adult Medicine): complete basic training and both divisional exams first, then compete for advanced-training posts in this specialty. This page covers what's specific to Medical Oncology.

Overview

Medical oncology delivers chemotherapy, targeted therapy and immunotherapy across tumour streams, anchored by long clinics and genuine relationships through the hardest chapters of patients' lives. The specialty's scientific tempo is extreme; practice-changing trials land monthly, and clinical-trials units make research a day-job option, not a hobby.

Selection and points

How selection works

ComponentWhat it involves
AT job applicationHospital-level; trials-heavy centres value research pedigree.
The unofficial view
  • A tumour-stream research project and strong communication reputation are the currency; palliative-care fluency is quietly essential and noticed.

Competition & demographics

Competitiveness

  • Moderately competitive; the big trials centres select academically.

Who's in the program

  • Majority-female trainees.

How to improve your chances at each stage

StageResident (PGY2–3)
  • Oncology BPT terms; join a trials unit as sub-investigator early if possible.
StageRegistrar years & applications
  • Pick AT sites across tumour-stream breadth; a first-author trials-adjacent paper opens academic doors.
StageIf you don't get on (or change your mind)
  • Adjacent: haematology, palliative medicine, radiation oncology (different college), general medicine.

See also the general strategy guide: universal CV, referee and interview advice that applies across specialties.

Job market & workforce outlook

Outlook: Demand rises with survivorship and drug pipeline; some metro consultant markets tightening as expanded cohorts fellow out, regional demand strong
  • Regional oncology chronically short (visiting models common); metro fellowships increasingly expected before tertiary consultant posts.

Income

  • $350,000–650,000 indicative with private infusion involvement; public-only below.

Pre-tax, indicative, and highly variable with hours, setting and billing model. ATO figures are averages of taxable income by reported occupation.

Subspecialties & special interests

AreaNotes
By tumour streamBreast, GI, lung, GU, melanoma…
Early-phase trialsAcademic centres

Community: questions and perspectives

CommunityAsk questions and share real-world experience below. Sign in with your email (button top right) to post. Your training stage and specialty interest appear beside your name so readers know the perspective, and the best posts are folded into the page at each annual review.

❓ Questions & answers

Loading…

🩺 Experiences, corrections & perspectives

If you've trained in medical oncology, or tried to, share what the page can't capture: what it's really like, what's changed, what you wish you'd known.

Loading…

Last reviewed July 2026. Details marked “verified” were checked against official/current sources at review; unmarked figures are indicative estimates from training data, college publications and community knowledge. Selection regulations change annually, always read the current-year official documents before acting.
↑